Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-18.26
Price to sales ratio
474.74

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2778
CRMD
CorMedix Inc. - Common Stock
7.52 USD+1.90%+2.87%-4.08%-33.45%586.14 M USD
2780
CTMX
CytomX Therapeutics, Inc. - Common Stock
2.48 USD-3.50%-1.98%-24.85%-27.91%540.39 M USD
2800
RGNX
REGENXBIO Inc. - Common Stock
8.04 USD-0.37%+1.64%-6.29%-40.13%530.75 M USD
2803
PBYI
Puma Biotechnology Inc - Common Stock
10.47 USD+1.75%+8.61%+15.05%+102.91%540.46 M USD

Frequently asked questions about DBV Technologies S.A. American Depositary Shares

What is the DBV Technologies S.A. American Depositary Shares stock price today?

The current price of DBV Technologies S.A. American Depositary Shares (DBVT) is 9.50. Over the past 24 hours, the stock has changed by -3.06%. Follow the DBVT chart for real-time price dynamics.

What is the stock ticker of DBV Technologies S.A. American Depositary Shares?

DBV Technologies S.A. American Depositary Shares trades under the ticker DBVT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is DBV Technologies S.A. American Depositary Shares stock going up?

DBVT has changed by -10.38% over the last week, -22.13% over the last month, and -35.55% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of DBV Technologies S.A. American Depositary Shares?

DBV Technologies S.A. American Depositary Shares currently has a market capitalization of 562.52 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were DBV Technologies S.A. American Depositary Shares earnings last quarter?

Last quarter, DBV Technologies S.A. American Depositary Shares reported earnings of -0.12 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was DBV Technologies S.A. American Depositary Shares revenue for the last quarter?

DBV Technologies S.A. American Depositary Shares reported quarterly revenue of 700 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was DBV Technologies S.A. American Depositary Shares net income for the last quarter?

DBV Technologies S.A. American Depositary Shares reported net income of -50.4 M for the last quarter. The previous quarter showed -47.6 M, which means net income changed by -5.88%.

How many employees does DBV Technologies S.A. American Depositary Shares have?

As of the latest available data, DBV Technologies S.A. American Depositary Shares has 170 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy DBV Technologies S.A. American Depositary Shares stock?

You can buy DBV Technologies S.A. American Depositary Shares (DBVT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in DBV Technologies S.A. American Depositary Shares stock?

Investing in DBV Technologies S.A. American Depositary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DBVT chart and related analysis on metatrader.com as part of your research.

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

News